UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CYP2C19 and CYP2D6 genotypes in Pacific peoples

British journal of clinical pharmacology, 2016-11, Vol.82 (5), p.1303-1307

Helsby, Nuala A.

2016

Volltextzugriff (PDF)

Trypanocidal Activity of Aziridinyl Nitrobenzamide Prodrugs

Antimicrobial Agents and Chemotherapy, 2010-10, Vol.54 (10), p.4246-4252

2010

Volltextzugriff (PDF)

Metabolomic Analysis Identifies Inflammatory and Noninflammatory Metabolic Effects of Genetic Modification in a Mouse Model of Crohn’s Disease

Journal of proteome research, 2010-04, Vol.9 (4), p.1965-1975

2010

Volltextzugriff (PDF)

Evaluating Aziridinyl Nitrobenzamide Compounds as Leishmanicidal Prodrugs

Antimicrobial Agents and Chemotherapy, 2014-01, Vol.58 (1), p.370-377

2014

Volltextzugriff (PDF)

Nontargeted Urinary Metabolite Profiling of a Mouse Model of Crohn’s Disease

Journal of proteome research, 2009-04, Vol.8 (4), p.2045-2057

2009

Volltextzugriff (PDF)

A systematic review of inter-individual differences in the DNA repair processes involved in melphalan monoadduct repair in relation to treatment outcomes

Cancer chemotherapy and pharmacology, 2021-11, Vol.88 (5), p.755-769

2021

Volltextzugriff (PDF)

Bystander Effects of Bioreductive Drugs: Potential for Exploiting Pathological Tumor Hypoxia with Dinitrobenzamide Mustards

Radiation research, 2007-06, Vol.167 (6), p.625-636

2007

Volltextzugriff (PDF)

Clozapine metabolism and cardiotoxicity: A prospective longitudinal study

International journal of cardiology, 2024-05, Vol.403, p.131788-131788, Article 131788

2024

Volltextzugriff (PDF)

The incidence, impact, and risk factors for moderate to severe persistent pain after breast cancer surgery: a prospective cohort study

Pain medicine (Malden, Mass.), 2023-09, Vol.24 (9), p.1023-1034

2023

Volltextzugriff (PDF)

A higher throughput assay for quantification of melphalan-induced DNA damage in peripheral blood mononuclear cells

Scientific reports, 2019-12, Vol.9 (1), p.18912-8, Article 18912

2019

Volltextzugriff (PDF)

The Prevalence, Impact, and Risk Factors for Persistent Pain After Breast Cancer Surgery in a New Zealand Population

Pain medicine (Malden, Mass.), 2019-09, Vol.20 (9), p.1803-1814

2019

Volltextzugriff (PDF)

Comparison of a thymine challenge test and endogenous uracil–dihydrouracil levels for assessment of fluoropyrimidine toxicity risk

Cancer chemotherapy and pharmacology, 2021-05, Vol.87 (5), p.711-716

2021

Volltextzugriff (PDF)

A simple ex vivo bioassay for 5-FU transport into healthy buccal mucosal cells

Cancer chemotherapy and pharmacology, 2019-10, Vol.84 (4), p.739-748

2019

Volltextzugriff (PDF)

A case–control study to assess the ability of the thymine challenge test to predict patients with severe to life threatening fluoropyrimidine‐induced gastrointestinal toxicity

British journal of clinical pharmacology, 2020-01, Vol.86 (1), p.155-164

2020

Volltextzugriff (PDF)

Pharmacogenomics in Papua New Guineans: unique profiles and implications for enhancing drug efficacy while improving drug safety

Pharmacogenetics and genomics, 2018-06, Vol.28 (6), p.153-164

2018

Volltextzugriff (PDF)

Using metabolomic analysis to understand inflammatory bowel diseases

Inflammatory bowel diseases, 2011-04, Vol.17 (4), p.1021-1029

2011

Volltextzugriff (PDF)

A high incidence of polymorphic CYP2C19 variants in archival blood samples from Papua New Guinea

Human genomics, 2008-09, Vol.3 (1), p.17-23

2008

Volltextzugriff (PDF)

Unravelling the role of SNM1 in the DNA repair system of Trypanosoma brucei

Molecular microbiology, 2015-05, Vol.96 (4), p.827-838

2015

Volltextzugriff (PDF)

Which CYP2B6 variants have functional consequences for cyclophosphamide bioactivation?

Drug metabolism and disposition, 2012-03, Vol.40 (3), p.635

2012

Volltextzugriff (PDF)

Validating TDP1 as an Inhibition Target for the Development of Chemosensitizers for Camptothecin-Based Chemotherapy Drugs

Oncology and therapy, 2021-12, Vol.9 (2), p.541-556

2021

Volltextzugriff (PDF)

Influence of mustard group structure on pathways of in vitro metabolism of anticancer N-(2-hydroxyethyl)-3,5-dinitrobenzamide 2-mustard prodrugs

Drug metabolism and disposition, 2008-02, Vol.36 (2), p.353-360

2008

Volltextzugriff (PDF)

Pharmacogenetics of drug-metabolizing enzymes: the prodrug hypothesis

Pharmacogenomics, 2012-01, Vol.13 (1), p.83-89

2012

Volltextzugriff (PDF)

The combined impact of CYP2C19 and CYP2B6 pharmacogenetics on cyclophosphamide bioactivation

British journal of clinical pharmacology, 2010-12, Vol.70 (6), p.844-853

2010

Volltextzugriff (PDF)

Metabolomic analysis reveals differences in urinary excretion of kiwifruit-derived metabolites in a mouse model of inflammatory bowel disease

Molecular nutrition & food research, 2011-12, Vol.55 (12), p.1900-1904

2011

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(80)
Dissertationen
(1)

Sprache

Englisch
(81)

Erscheinungsjahr

n.n

Thema

Science & Technology
(54)
Life Sciences & Biomedicine
(52)
Humans
(32)
Pharmacology & Pharmacy
(32)
Animals
(16)
Male
(13)
Biological And Medical Sciences
(11)
Genotype
(11)
Female
(10)
Medical Sciences
(10)
Mice
(10)
Oncology
(9)
Toxicology
(9)
Pharmacology
(8)
Phenotype
(8)
Adult
(7)
Aryl Hydrocarbon Hydroxylases - Genetics
(7)
Cytochrome P-450 Cyp2c19
(7)
Middle Aged
(7)
Pharmacogenetics
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

CYP2C19 and CYP2D6 genotypes in Pacific peoples

Trypanocidal Activity of Aziridinyl Nitrobenzamide Prodrugs

Metabolomic Analysis Identifies Inflammatory and Noninflammatory Metabolic Effects of Genetic Modification in a Mouse Model of Crohn’s Disease

Evaluating Aziridinyl Nitrobenzamide Compounds as Leishmanicidal Prodrugs

Nontargeted Urinary Metabolite Profiling of a Mouse Model of Crohn’s Disease

A systematic review of inter-individual differences in the DNA repair processes involved in melphalan monoadduct repair in relation to treatment outcomes

Bystander Effects of Bioreductive Drugs: Potential for Exploiting Pathological Tumor Hypoxia with Dinitrobenzamide Mustards

Clozapine metabolism and cardiotoxicity: A prospective longitudinal study

The incidence, impact, and risk factors for moderate to severe persistent pain after breast cancer surgery: a prospective cohort study

A higher throughput assay for quantification of melphalan-induced DNA damage in peripheral blood mononuclear cells

The Prevalence, Impact, and Risk Factors for Persistent Pain After Breast Cancer Surgery in a New Zealand Population

Comparison of a thymine challenge test and endogenous uracil–dihydrouracil levels for assessment of fluoropyrimidine toxicity risk

A simple ex vivo bioassay for 5-FU transport into healthy buccal mucosal cells

A case–control study to assess the ability of the thymine challenge test to predict patients with severe to life threatening fluoropyrimidine‐induced gastrointestinal toxicity

THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes

Pharmacogenomics in Papua New Guineans: unique profiles and implications for enhancing drug efficacy while improving drug safety

Using metabolomic analysis to understand inflammatory bowel diseases

A high incidence of polymorphic CYP2C19 variants in archival blood samples from Papua New Guinea

Unravelling the role of SNM1 in the DNA repair system of Trypanosoma brucei

Which CYP2B6 variants have functional consequences for cyclophosphamide bioactivation?

Validating TDP1 as an Inhibition Target for the Development of Chemosensitizers for Camptothecin-Based Chemotherapy Drugs

Influence of mustard group structure on pathways of in vitro metabolism of anticancer N-(2-hydroxyethyl)-3,5-dinitrobenzamide 2-mustard prodrugs

Pharmacogenetics of drug-metabolizing enzymes: the prodrug hypothesis

The combined impact of CYP2C19 and CYP2B6 pharmacogenetics on cyclophosphamide bioactivation

Metabolomic analysis reveals differences in urinary excretion of kiwifruit-derived metabolites in a mouse model of inflammatory bowel disease

Suchergebnisse filtern